India now offers Awiqli, a new once-weekly basal insulin for diabetes patients. This drug reduces annual injections from 365 ...

India has become one of the first countries in the world to introduce Awiqli, the world's first once-a-week basal insulin ...

Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side ...

One injection a week instead of one every day. Danish drugmaker Novo Nordisk has launched Awiqli, or insulin icodec, in India-the world's first once-weekly bas ...

Novo Nordisk says it is the world's first once-weekly basal insulin approved for clinical use, which is prescribed for the ...

Awiqli, the world's first once-a-week basal insulin, has been launched in India, reducing insulin injections from 365 to 52 a ...

Insulin initiation in India is often delayed due to fear of injections & pain, treatment complexity & adherence concerns.

Sept 11 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present the latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free ...

New research published in New England Journal of Medicine and presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Madrid (9–13 Sept) shows that a ...

A major breakthrough for diabetes care has arrived in India. Novo Nordisk has launched Awiqli, the world's first once-weekly ...

To reduce these obstacles, researchers around the world are looking for more patient-friendly ways of delivering insulin. Recently, a team from the U.S., Canada, Denmark, the United Kingdom, Poland, ...

India has become one of the first countries to introduce Awiqli, the world’s first once-weekly basal insulin for adults with ...